Joshua Cohen

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

AMLX

Current role

CEO, Board Member

2014-01-01–present

7 calls Latest call 2026-05-07

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Amylyx Pharmaceuticals, Inc. (AMLX)	Co-Chief Executive Officer and Director	$686,200	—	$650,226	$817,783	$548,098	$17,500	$2,719,807
2024	Amylyx Pharmaceuticals, Inc. (AMLX)	Co-Chief Executive Officer and Director	$686,200	—	$2,585,771	$2,685,179	$521,855	$17,250	$6,496,255
2023	Amylyx Pharmaceuticals, Inc. (AMLX)	Co-Chief Executive Officer and Director	$621,000	—	$1,604,000	$4,733,928	$447,741	$11,500	$7,418,169
2022	Amylyx Pharmaceuticals, Inc. (AMLX)	Co-Chief Executive Officer and Director	$539,275	—	$1,425,000	$4,752,000	$452,991	$9,150	$7,178,416
2021	Amylyx Pharmaceuticals, Inc. (AMLX)	Co-Chief Executive Officer and Director	$417,833	—	—	$698,000	$300,000	$8,700	$1,424,533
2020	Amylyx Pharmaceuticals, Inc. (AMLX)	Co-Chief Executive officer and Director	$370,000	—	—	$97,000	$203,500	—	$670,500

Earnings-call appearances and filed executive appointments or departures, newest first.